Drug intelligence / Profile preview

phentermine resin

Development stage
Approved
Lead developer
UnitedBiosource
Modality
Small Molecules
Administration
Oral
01

Overview

Phentermine resin is an extended-release formulation of phentermine, a sympathomimetic amine anorectic. It is prescribed for the short-term management of exogenous obesity as an adjunct to a comprehensive weight reduction program involving exercise, behavioral modification, and caloric restriction. The drug functions as a central nervous system stimulant, primarily by promoting the release of norepinephrine and dopamine, and to a lesser extent, serotonin, which leads to appetite suppression and increased satiety. Additionally, it may inhibit neuropeptide Y, a key pathway for hunger induction. Phentermine resin is a Schedule IV controlled substance due to its potential for abuse and dependence.

Brand names
IonaminPhentercot
Other names
Phentermine ResinePhentermin-Resin
02

Targets

DAT (Dopamine plasma membrane transport protein)TAAR1 (Trace amine-associated receptor 1)SERT (Sodium-dependent serotonin transporter)NET (Norepinephrine Transporter)MAOA (Monoamine oxidase A)

Beyond the preview

Go deeper on phentermine resin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on phentermine resin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call